glutamine has been researched along with Behavior Disorders in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (28.57) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 10 (47.62) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Bejerot, S; Eklund, D; Humble, MB; Hylén, U; Hyötyläinen, T; Salihovic, S; Särndahl, E | 1 |
| Bustillo, JR | 1 |
| Chen, G; Cheng, L; Chiang, CH; Christian, KM; Guo, Z; Guzman, E; Kaibuchi, K; Kim, NS; Kosik, KS; Lalli, MA; Makri, G; Margolis, RL; Ming, GL; Nauen, D; Nguyen, HN; Ross, CA; Shin, J; Song, H; Su, Y; Wang, X; Wen, Z; Yoon, KJ; Yoritomo, N; Yu, H; Zhang, C; Zou, J | 1 |
| Bargalló, N; Falcon, C; Gassó, P; Lafuente, A; Lázaro, L; Mas, S; Ortiz, AE | 1 |
| Huang, Q; Shen, Z; Wu, R; Xu, H; Zhang, H; Zhang, J | 1 |
| Parpura, V; Peng, L; Steardo, L; Verkhratsky, A | 1 |
| Campagna, G; Grilli, A; La Fratta, I; Pesce, M; Rizzuto, A; Tatangelo, R | 1 |
| Barker, GJ; Day, F; Lythgoe, DJ; McGuire, PK; McLean, MA; O'Gorman, RL; Stone, JM; Tsagaraki, H; Valli, I | 1 |
| Arranz, JA; Artuch, R; Briones, P; Campistol, J; Fons, C; García-Cazorla, A; Gómez-López, L; Häberle, J; Jara, F; Martins, C; Murgui, E; Pérez-Dueñas, B; Pineda, M; Serrano, M; Vilaseca, MA | 1 |
| Agostino, MJ; Brandon, NJ; Brennan, J; Comery, TA; Day, JP; Dwyer, JM; Grauer, SM; Houslay, MD; Jiang, L; Kelley, C; Kelly, MP; Lakkaraju, S; Logue, SF; Murrills, RJ; Navarra, RL; Neal, S; Platt, BJ; Pulito, VL; Sukoff Rizzo, SJ; Tam, M; Zhong, X | 1 |
| HARRIS, MM; HARRIS, RS; ROTH, RT | 1 |
| Bettler, B; Bradaia, A; Caron, MG; Chaboz, S; Durkin, S; Gainetdinov, RR; Hoener, MC; Metzler, V; Meyer, CA; Moreau, JL; Mory, R; Norcross, R; Ozmen, L; Pouzet, B; Revel, FG; Sotnikova, TD; Trube, G; Wettstein, JG; Zbinden, KG | 1 |
| Buonocore, MH; Maddock, RJ | 1 |
| VRBA, R | 1 |
| Postolache, TT; Sternberg, EM; Tonelli, LH | 1 |
| Abdolmaleky, HM; Thiagalingam, S; Wilcox, M | 1 |
| Cocchi, R; Fusari, A; Lorini, G; Roccia, L | 1 |
| Montini, M; Ongaro, A; Simonutti, M | 1 |
| Cocchi, R; Favuto, F; Fusari, A; Lorini, G | 1 |
| Martini, GA | 1 |
| Gel'fgat, EB; Kulieva, SF | 1 |
6 review(s) available for glutamine and Behavior Disorders
| Article | Year |
|---|---|
Use of proton magnetic resonance spectroscopy in the treatment of psychiatric disorders: a critical update.
Topics: Animals; Brain; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Mental Disorders; Protons; Treatment Outcome | 2013 |
Evaluation of neuron-glia integrity by in vivo proton magnetic resonance spectroscopy: Implications for psychiatric disorders.
Topics: Brain; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Mental Disorders; Neuroglia; Neurons; Proton Magnetic Resonance Spectroscopy | 2016 |
The progression of coeliac disease: its neurological and psychiatric implications.
Topics: Adult; Celiac Disease; Cognitive Dysfunction; Diet, Gluten-Free; Disease Progression; Edible Grain; Environment; Female; Genetic Predisposition to Disease; Glutamine; Humans; Immune System Diseases; Immunity; Male; Mental Disorders; Middle Aged; Nervous System Diseases; Plant Proteins; Proline | 2017 |
MR spectroscopic studies of the brain in psychiatric disorders.
Topics: Aspartic Acid; Brain; Creatine; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Mental Disorders | 2012 |
Inflammatory genes and neural activity: involvement of immune genes in synaptic function and behavior.
Topics: Animals; Brain; Chemokines; Cytokines; Gene Expression Regulation; Glutamine; Humans; Immune System; Inflammation; Major Histocompatibility Complex; Mental Disorders; Neurons; Synapses; Synaptic Transmission; Tumor Necrosis Factor-alpha | 2005 |
Genetics and epigenetics in major psychiatric disorders: dilemmas, achievements, applications, and future scope.
Topics: Brain; Cell Adhesion Molecules, Neuronal; Dopamine; Epigenesis, Genetic; Extracellular Matrix Proteins; Glutamine; Humans; Mental Disorders; Models, Genetic; Nerve Tissue Proteins; Pharmacogenetics; Receptors, Neurotransmitter; Reelin Protein; Serine Endopeptidases; Serotonin | 2005 |
1 trial(s) available for glutamine and Behavior Disorders
| Article | Year |
|---|---|
[Controlled clinical study and clinico-psychological evaluation of a preparation with neurotrophic effects].
Topics: Aged; Arginine; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Female; Glutamine; Humans; Male; Mental Disorders; Middle Aged; Nervous System Diseases; Organophosphorus Compounds; Serine; Threonine; Tryptophan; Vitamin B 12 | 1977 |
14 other study(ies) available for glutamine and Behavior Disorders
| Article | Year |
|---|---|
Alterations in inflammasome-related immunometabolites in individuals with severe psychiatric disorders.
Topics: Aged; Glutamine; Humans; Inflammasomes; Inflammation; Mental Disorders; NLR Family, Pyrin Domain-Containing 3 Protein; Quality of Life | 2023 |
Synaptic dysregulation in a human iPS cell model of mental disorders.
Topics: Animals; Cell Differentiation; Fibroblasts; Glutamine; Humans; Induced Pluripotent Stem Cells; Male; Mental Disorders; Mice; Mutant Proteins; Mutation; Nerve Tissue Proteins; Neurons; Pedigree; Presynaptic Terminals; Prosencephalon; Protein Binding; Synapses; Transcriptome | 2014 |
Association between genetic variants of serotonergic and glutamatergic pathways and the concentration of neurometabolites of the anterior cingulate cortex in paediatric patients with obsessive-compulsive disorder.
Topics: Child; Comorbidity; Female; Genetic Predisposition to Disease; Genetic Variation; Genotype; Glutamine; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Mental Disorders; Neural Pathways; Neurons; Obsessive-Compulsive Disorder; Polymorphism, Single Nucleotide; Serotonergic Neurons; Statistics as Topic; Young Adult | 2016 |
Astroglia, Glutamatergic Transmission and Psychiatric Diseases.
Topics: Astrocytes; Glutamic Acid; Glutamine; Humans; Mental Disorders; Neurons; Synaptic Transmission | 2016 |
Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume.
Topics: Adult; Brain Mapping; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mental Disorders; Protons; Psychiatric Status Rating Scales; Risk; Temporal Lobe; Thalamus; Young Adult | 2009 |
Neuropsychiatric manifestations in late-onset urea cycle disorder patients.
Topics: Adolescent; Adult; Age of Onset; Carbamoyl-Phosphate Synthase I Deficiency Disease; Child; Child, Preschool; Citrullinemia; Female; Follow-Up Studies; Glutamine; Humans; Male; Mental Disorders; Ornithine Carbamoyltransferase Deficiency Disease; Quaternary Ammonium Compounds; Retrospective Studies; Treatment Outcome; Urea Cycle Disorders, Inborn | 2010 |
Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Behavior, Animal; Female; Gene Expression Regulation, Enzymologic; Glutamine; Hippocampus; Male; Mental Disorders; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Signal Transduction; Social Behavior | 2010 |
Studies regarding glutamine and ammonia in the cerebrospinal fluid of patients with nervous and mental diseases (with some observations on insulin hypoglycemic shock and oligophrenia phenylpyruvica).
Topics: Ammonia; Cerebrospinal Fluid; Glutamine; Humans; Hypoglycemic Agents; Insulin; Intellectual Disability; Mental Disorders; Nervous System Diseases; Neurotic Disorders; Phenylketonurias; Psychopathology; Psychotic Disorders | 1945 |
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity.
Topics: Animals; Benzodioxoles; Biogenic Monoamines; Dopamine; Glutamine; HEK293 Cells; Humans; Mental Disorders; Mice; Phenylpropionates; Receptors, G-Protein-Coupled; Synaptic Transmission | 2011 |
[Studies on metabolic function of the brain and its relation to physical stress. II. Ammonia and glutamine].
Topics: Ammonia; Brain; Exercise; Glutamine; Mental Disorders; Neurochemistry | 1954 |
[Acupunctura, "vital" drugs and psychopharmacological agents in the treatment of psychiatric patients with deep depressive disorders, with considerations on the probable neurophysiological mechanisms of the synergism of action].
Topics: Acupuncture Therapy; Adolescent; Adult; Aged; Female; Glutamine; Humans; Male; Mental Disorders; Middle Aged; Psychotropic Drugs; Valerates; Valproic Acid | 1977 |
[Acupuncture, "vital" drugs and psychotropic agents in psychiatric patients. 50 cases].
Topics: Acupuncture Therapy; Adolescent; Adult; Aged; Drug Evaluation; Evaluation Studies as Topic; Female; Glutamine; Humans; Male; Mental Disorders; Middle Aged; Psychotropic Drugs; Time Factors; Valproic Acid | 1978 |
[Psychiatric-neurological disorders in chronic liver diseases].
Topics: Acute Disease; Ammonia; Biotransformation; Brain Damage, Chronic; Brain Diseases; Chronic Disease; Dietary Proteins; Diuretics; Glutamine; Humans; Lactulose; Liver Diseases; Mental Disorders; Portacaval Shunt, Surgical; Postoperative Complications; Prognosis | 1975 |
[Evaluation of the effectiveness of drug correction of impaired cognitive activity in chronic cardiac insufficiency].
Topics: Attention; Chronic Disease; Female; Glutamine; Heart Failure; Hemodynamics; Humans; Male; Memory; Mental Disorders; Middle Aged; Thinking | 1991 |